Reference field note
Bremelanotide
A reference record with its source links, an editorial reading note, and questions to carry forward.
Aliases: Vyleesi
- Status
- Approved product
- Evidence label
- Randomized evidence
- Index topics
- Sexual health
- Status as of
The record
Recorded fields
- Mechanism
- Melanocortin-receptor agonist.
- Evidence
- Randomized trials.
- Limitations
- Exclude medical, relationship and drug causes; not performance enhancement.
- Safety
- Uncontrolled hypertension or known cardiovascular disease: contraindicated.
- Route context
- Subcutaneous injection.
- Approval scope
- Vyleesi: eligible premenopausal women with distressing acquired generalized low-desire disorder.
Pause and consider
A reading note
A reading aid can organize a page without telling you what conclusion to draw. Headings, filters, and grouped links help locate material; their arrangement does not explain why a particular conclusion would follow. Use the aid to reach a passage, then examine the argument in that passage on its own terms. If a category seems to answer your question immediately, ask what extra meaning you have given it. Keeping navigation separate from judgment lets a convenient layout remain helpful without allowing the layout to become an unstated rule for deciding what to believe.
Questions to carry forward
- Is this feature helping me locate material or supplying a reason for a conclusion?
- What extra meaning might I be attaching to the way the page is arranged?
- Which passage contains the argument I need to examine after using the reading aid?
Follow the record
References
- VYLEESI
NLM · Checked
- Kingsberg trials
PubMed · Checked
Prepared by the Panda Bear editorial team. Educational information; no independent medical review is claimed.